Peter H Wiernik

6PUBLICATIONS
7CO-AUTHORS
Respiratory diseasesHaematological tumoursMedical infection agents (incl. prions)Obstetrics and gynaecologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 19, 2025
Mortality and relapse dynamics in AML after three years of complete remission.

Samuel Urrutia, Wei-Ying Jen, Koji Sasaki

|Jul 18, 2024
Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.

C Ganzel, Y Wang, K Roopcharan

|May 22, 2024
Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.

C Ganzel, Y Wang, K Roopcharan

|Nov 07, 2022
Higher than normal mitochondrial DNA content associated with better outcome in acute promyelocytic leukaemia? Maybe.

Peter H Wiernik

|Jun 19, 2021
Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia.

Peter H Wiernik, Zhuoxin Sun, Larry D Cripe

|Feb 05, 2021
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2.

Joseph I Clark, Brendan Curti, Elizabeth J Davis

Pageof 1

Frequent Collaborators

2 joint publications

C Ganzel

2 joint publications

H M Lazarus

2 joint publications

M R Litzow

1 joint publications

Janice P Dutcher